Pharmaceutical Reports
Facing patent expirations, pricing pressures, and R&D productivity challenges, pharma companies are relying on market research and consulting services to identify growth opportunities, demonstrate value, and bring innovative therapies to market. This guide provides insights into the pharma consulting landscape.
Aminoglycoside Antibiotics Market
Aminoglycoside Antibiotics Market, By Product Type (Amikacin, Gentamicin, Tobramycin, Neomycin, Streptomycin, Paromomycin, Others), By Route of Administration (Intravenous, Intramuscular, Topical, Inhalation, Others), By Application (Respiratory Tract Infections, Urinary Tract Infections, Septicemia, Endocarditis, Meningitis, Bone and Joint Infections, Others), By End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Others), By Spectrum of Activity (Broad-spectrum, Narrow-spectrum), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, DNA/RNA Synthesis Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Pfizer Inc., Novartis AG, Sanofi, Merck & Co., Inc., GlaxoSmithKline plc, Bayer AG
Ambroxol Market
Ambroxol Market, By Product Type (Oral formulations (Syrups, Tablets, Capsules), Inhalation formulations (Nebulizers, Dry powder inhalers), Parenteral formulations, Others), By Indication (Chronic Bronchitis, Bronchiectasis, Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Others), By Age Group (Pediatrics, Adults, Geriatrics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Clinics, Homecare Settings, Others), By Drug Formulation (Single-ingredient formulations, Combination formulations, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Boehringer Ingelheim, Sanofi, Mylan, Novartis, Teva Pharmaceutical Industries, GlaxoSmithKline
Menopause Market
Menopause Market, By Product Type (Hormonal Therapy, Non-Hormonal Therapy, Combination Therapy, Others), By Route of Administration (Oral, Transdermal, Vaginal, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Treatment Type (Vasomotor Symptoms, Vaginal Atrophy, Osteoporosis, Others), By End-User (Hospitals, Gynecology Clinics, Homecare Settings, Others), By Therapy (Estrogen Therapy, Progestin Therapy, Combined Hormone Therapy, Selective Estrogen Receptor Modulators, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Pfizer Inc., Novartis AG, Merck & Co., Inc., Bayer AG, Allergan plc, Novo Nordisk A/S
Heavy Menstrual Bleeding (HMB) Market
Heavy Menstrual Bleeding (HMB) Market, By Treatment Type (Medications, Surgical Interventions, Other Treatments), By Disease Type (Uterine Fibroids, Endometriosis, Adenomyosis, Hormonal Imbalances, Others), By Route of Administration (Oral, Parenteral, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Device Type (Endometrial Ablation Devices, Hysteroscopes, Resectoscopes, Others), By Technology (Radiofrequency Ablation, Cryoablation, Thermal Balloon Ablation, Hydrothermal Ablation, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Bayer AG, Ferring Pharmaceuticals, Myovant Sciences, Allergan plc, Gedeon Richter Plc, Hologic, Inc.
Fibrocystic Breast Condition Market
Fibrocystic Breast Condition Market, By Treatment Type (Hormone Therapy, Pain Medication, Surgery, Lifestyle Modifications, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Specialty Clinics, Gynecology Centers, Others), By Age Group (Below 30 Years, 30-39 Years, 40-49 Years, 50-59 Years, 60 Years and Above), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Genzyme Corporation, AstraZeneca, Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Bayer AG
Anovulation Market
Anovulation Market, By Treatment Type (Medication, Assisted Reproductive Technology (ART), Surgical Intervention, Others), By Disease Indication (Polycystic Ovary Syndrome (PCOS), Hypothalamic Amenorrhea, Premature Ovarian Failure, Hyperprolactinemia, Thyroid Disorders, Others), By Route of Administration (Oral, Injectable, Implants, Others), By End-user (Hospitals, Fertility Clinics, Academic and Research Institutes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Age Group (Below 25 Years, 25-35 Years, 35-45 Years, above 45 Years), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Merck & Co., Inc., Ferring Pharmaceuticals, Bayer AG, Novartis AG, Pfizer Inc., Sanofi
Bacterial Vaginosis Market
Bacterial Vaginosis Market, By Treatment Type (Antibiotics, Probiotics, Prebiotics, Combination Therapy, Others), By Route of Administration (Oral, Vaginal, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Specialty Clinics, Gynecology Centers, Others), By Dosage Form (Tablets, Capsules, Gels, Creams, Suppositories, Injections, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Lupin Pharmaceuticals, Symbiomix Therapeutics, Starpharma Holdings, Merck & Co., Pfizer Inc.
Endometriosis Market
Endometriosis Market, By Treatment Type (Hormonal Therapy, Non-Hormonal Therapy, Surgical Treatment, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Gynecology Clinics, Fertility Centers, Research Institutes, Others), By Age Group (Below 30 Years, 30-45 Years, Above 45 Years), By Severity (Minimal, Mild, Moderate, Severe), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: AbbVie, Bayer AG, Pfizer, Myovant Sciences, ObsEva SA, Ferring Pharmaceuticals
Epithelial Ovarian Cancer Market
Epithelial Ovarian Cancer Market, By Treatment Type (Chemotherapy, Targeted Therapy, Hormone Therapy, Surgery, Others), By Cancer Type (Epithelial Ovarian Cancer, Germ Cell Ovarian Cancer, Stromal Ovarian Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Clinics, Cancer Research Institutes, Others), By Stage (Early-Stage (Stage I, Stage II), Advanced Stage), By Molecule Type (Small Molecules, Biologics, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: AstraZeneca, GlaxoSmithKline, Roche, Merck & Co., Pfizer, Johnson & Johnson, Novartis
Fallopian Tube Cancer Market
Fallopian Tube Cancer Market, By Treatment Type (Chemotherapy, Targeted Therapy, Hormone Therapy, Radiation Therapy Surgery), By Route of Administration (Oral, Parenteral, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Drug Type (Branded, Generics), By Molecule Type (Small Molecules, Biologics, Others), By Stage at Diagnosis (Early Stage (Stage I and II), Advanced Stage (Stage III and IV), Recurrent), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: AstraZeneca, GlaxoSmithKline, Merck & Co., Roche, Pfizer, Novartis, Eli Lilly and Company